ATI RN
ATI Pharmacology 2023 III Questions
Extract:
Question 1 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: D
Rationale:
Correct
Answer: D - Administer the medication into the anterolateral or posterolateral abdominal area.
Rationale: Enoxaparin is a type of anticoagulant medication that is typically administered subcutaneously. The abdomen is a common site for subcutaneous injections due to its ample subcutaneous tissue and fewer major blood vessels compared to other areas. Administering enoxaparin in the anterolateral or posterolateral abdominal area helps to minimize the risk of hitting blood vessels or nerves, reducing the likelihood of complications.
Incorrect
Choices:
A: Massaging the injection site after administering the medication is not recommended as it can cause bruising or discomfort.
B: Expelling the air bubble from the syringe is not necessary for subcutaneous injections and may result in medication wastage.
C: Holding the skin taut at the injection site is not required for subcutaneous injections and may cause unnecessary discomfort to the client.
Question 2 of 5
A nurse is teaching a client who has a new prescription for captopril. Which of the following information should the nurse include in the teaching?
Correct Answer: D
Rationale: The correct answer is D: Exercise caution when changing positions. This is important to prevent dizziness and potential falls due to captopril's tendency to lower blood pressure. A: Taking extra potassium can lead to hyperkalemia, a dangerous side effect. B: Monitoring pulse rate is not necessary for captopril. C: Increasing sodium intake contradicts the medication's purpose of lowering blood pressure. E, F, and G are not applicable.
Question 3 of 5
A nurse is caring for a client who started haloperidol five days ago and is experiencing neuroleptic malignant syndrome. Which of the following prescriptions should the nurse anticipate administering?
Correct Answer: C
Rationale: The correct answer is C: Bromocriptine. Bromocriptine is used to treat neuroleptic malignant syndrome, a rare but serious side effect of antipsychotic medications like haloperidol. It works by increasing dopamine levels in the brain, helping to alleviate symptoms of muscle rigidity, fever, and altered mental status associated with neuroleptic malignant syndrome. Benztropine (
Choice
A) is an anticholinergic medication used to treat extrapyramidal symptoms, not neuroleptic malignant syndrome. Naloxone (
Choice
B) is used to reverse opioid overdose. Diphenhydramine (
Choice
D) is an antihistamine and not indicated for neuroleptic malignant syndrome.
Question 4 of 5
A nurse is caring for a client who is taking digoxin to treat heart failure. Which of the following factors predisposes this client to developing digoxin toxicity?
Correct Answer: A
Rationale: The correct answer is A: Taking a high-ceiling diuretic. High-ceiling diuretics, such as furosemide, can lead to hypokalemia, which increases the risk of digoxin toxicity. Digoxin toxicity occurs when digoxin levels in the body become too high, leading to symptoms like nausea, vomiting, and visual disturbances.
Choices B, C, and D are incorrect because they do not directly predispose the client to digoxin toxicity. HMG COA reductase inhibitors are used to lower cholesterol levels, COPD is a respiratory condition, and a prolapsed mitral valve is a heart valve issue.
Question 5 of 5
A nurse is caring for a client who is receiving ondansetron IV. Which of the following findings is an indication that the ondansetron is effective?
Correct Answer: A
Rationale: The correct answer is A: Decreased nausea. Ondansetron is an antiemetic medication used to treat nausea and vomiting.
Therefore, if the client is receiving ondansetron IV and their nausea is decreased, it indicates that the medication is effective in managing their symptoms. Reduced dizziness (
B) and absence of peripheral neuropathy (
D) are not direct indicators of ondansetron effectiveness. Increased urinary output (
C) is not related to the medication's mechanism of action.